Medication Management in Inflammatory Bowel Disease

Marc O'Connor, chief operating officer of Curant Health, discusses counseling patients on a therapeutic regimen for IBD.

Related Content:

InterviewsSpecialty Pharmacy

Establishing Workflow for In-clinic, Home Administration of Cabotegravir-rilpivirine Injections for HIV-1

Data Points Show Value in Oncology Pharmacy

Updates in Prevention, Treatment of Cytokine Release Syndrome, Neurologic Toxicities for Patients With Multiple Myeloma